http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2607960-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d584042a524740a406723fe1631e49e5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-42
filingDate 2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b06324102481b9d391e826bee2e55099
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_435d8acbb28976966e7e453b90320877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1676f2dec51c3582fdf3c26696de63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03177560a6f638b2afdb44a54f5608e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e87f35d668e9432134637f1e65619663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16ee11c929e4bb3798b00642051cc54e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb4c2a666e5a9f818aa19b47dca9e171
publicationDate 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2607960-C1
titleOfInvention Device and method for intraoperative lymphorrhea prevention in patients with cervical cancer after extended surgeries with pelvic lymph node dissection
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to oncology. “Zhelplastan” is used for intraoperative lymphorrhea prevention in patients with cervical cancer with pelvic lymphadenectomy. Wherein drainage tubes are installed in retroperitoneum, ends of which are discharged into lower angle of postoperative wound through round ligament of womb or through vagina stump. Additionally, before installation of drainage tubes bed of removed lymph nodes is insufflated with sterile powder “Zhelplastan”, which is distributed with dry gauze swab along whole surface of wound pocket. n EFFECT: method increases efficiency of lymphorrhea prevention and improving quality of life of patients due to reduction of duration and volume of lymphorrhea, reduced percentage of developing lymphatic cysts, reducing length of drainage, which promotes timely performance of further stages of combination treatment of cervical cancer patients. n 2 cl, 1 tbl
priorityDate 2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2532898-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2067447-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2362495-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452051671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160417414

Total number of triples: 27.